Revance to Host Investor Day on September 19, 2023
August 22 2023 - 8:00AM
Business Wire
Revance Therapeutics, Inc. (Nasdaq: RVNC) today announced that
the company will host an Investor Day on September 19, 2023, from
9:30 AM ET to 1:00 PM ET.
Interested parties can attend the live webcast for the event by
registering on the Events and Presentation section of the
company’s Investor Relations webpage. A webcast replay will be
available beginning September 19, 2023, at 12:00 p.m. PT / 3:00
p.m. ET.
About Revance
Revance is a biotechnology company setting the new standard in
healthcare with innovative aesthetic and therapeutic offerings that
enhance patient outcomes and physician experiences. Revance’s
portfolio includes DAXXIFY® (DaxibotulinumtoxinA-lanm) for
injection, the RHA® Collection of dermal fillers in the U.S., and
value-added services including the OPUL® Relational Commerce
platform for aesthetic practices.
Revance has also partnered with Viatris Inc. to develop a
biosimilar to onabotulinumtoxinA for injection and Shanghai Fosun
Pharmaceutical to commercialize DAXXIFY® in China.
Revance is headquartered in Nashville, Tenn., with additional
office locations in Newark and Irvine, Calif. Learn more
www.revance.com, www.RevanceAesthetics.com,
www.DAXXIFY.com, www.hcp.daxxifytherapy.com, or
connect with us on LinkedIn.
“Revance” and the Revance logo, DAXXIFY®, and OPUL® are
registered trademarks of Revance Therapeutics, Inc. Resilient
Hyaluronic Acid® and RHA® are trademarks of TEOXANE SA.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230822424203/en/
Investors Revance Therapeutics, Inc.: Jessica Serra,
510-279-6886 jessica.serra@revance.com or Gilmartin Group, LLC.:
Laurence Watts, 619-916-7620 laurence@gilmartinir.com Media
Revance Therapeutics, Inc.: Sara Fahy, 949-887-4476
sfahy@revance.com
Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From Jul 2023 to Jul 2024